Pancreatic Cancer Research

ResearcherTang Du HospitalActive in the last 2 years

Haichuan Su

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3316-9959; OpenAlex author ID A5017875824, A5125093106. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 10)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: 3 papers · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 10

  1. KRAS-driven protein disulfide isomerase family A member 6 expression suppresses PRKR-like endoplasmic reticulum kinase-mediated immunogenic cell death to desen… Last author DOI 10.1136/gutjnl-2025-335641↗
  2. Ran drives pancreatic cancer metastasis by activating the osteopontin-PI3K/AKT-androgen receptor signaling cascade. Last author DOI 10.1016/j.taap.2025.117328↗
  3. The type I collagen paradox in PDAC progression: microenvironmental protector turned tumor accomplice. Last author DOI 10.1186/s12967-025-06778-8↗
  4. AKR7A3 modulates the metastasis of pancreatic ductal adenocarcinoma through regulating PHGDH-suppressed autophagy. Last author DOI 10.1111/cas.15798↗
  5. Machine learning-based integration develops a metabolism-derived consensus model for improving immunotherapy in pancreatic cancer. Last author DOI 10.1136/jitc-2023-007466↗
  6. Correction: TMEM43 promotes pancreatic cancer progression by stabilizing PRPF3 and regulating RAP2B/ERK axis. Last author DOI 10.1186/s11658-023-00419-y↗
  7. TMEM43 promotes pancreatic cancer progression by stabilizing PRPF3 and regulating RAP2B/ERK axis. Last author DOI 10.1186/s11658-022-00321-z↗
  8. Comprehensive Analysis of 5-Methylcytosine (m5C) Regulators and the Immune Microenvironment in Pancreatic Adenocarcinoma to Aid Immunotherapy. Last author DOI 10.3389/fonc.2022.851766↗
  9. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer. Last author DOI 10.3389/fimmu.2021.769425↗
  10. Label-Free Quantitative Proteomics Unravels Carboxypeptidases as the Novel Biomarker in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1016/j.tranon.2018.03.005↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ronglin Wang · 7 shared papers, 2021–2025 · strength 1.13
  2. Yongdong Guo · 6 shared papers, 2021–2023 · strength 0.84
  3. Junqiang Li · 5 shared papers, 2021–2025 · strength 0.80
  4. Lei Hua · 5 shared papers, 2021–2023 · strength 0.69
  5. Yang Song · 4 shared papers, 2018–2023 · strength 0.47
  6. Cheng Yang · 3 shared papers, 2021–2022 · strength 0.37
  7. Cheng Yang · 1 shared paper, 2025 · strength 0.28
  8. Qian Li · 1 shared paper, 2025 · strength 0.28
  9. Linhong Deng · 1 shared paper, 2025 · strength 0.27
  10. Ting Zhao · 2 shared papers, 2021–2022 · strength 0.24
  11. Ronglin Wang · 1 shared paper, 2026 · strength 0.23
  12. Qing Wang · 1 shared paper, 2018 · strength 0.08
  13. Desheng Wang · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.